Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · IEX Real-Time Price · USD
3.510
-0.090 (-2.50%)
Apr 18, 2024, 1:05 PM EDT - Market open
Kodiak Sciences Market Cap
Kodiak Sciences has a market cap or net worth of $183.52 million as of April 18, 2024. Its market cap has decreased by -24.76% in one year.
Market Cap
183.52M
Enterprise Value
-27.21M
1-Year Change
-24.76%
Ranking
Category
Stock Price
$3.51
Market Cap Chart
Since October 4, 2018, Kodiak Sciences's market cap has decreased from $359.30M to $183.52M, a decrease of -48.92%. That is a compound annual growth rate of -11.43%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 16, 2024 | 204.30M | 0.54% |
Apr 15, 2024 | 203.20M | -12.26% |
Apr 12, 2024 | 231.60M | -1.11% |
Apr 11, 2024 | 234.20M | -0.43% |
Apr 10, 2024 | 235.20M | 0.21% |
Apr 9, 2024 | 234.70M | 4.17% |
Apr 8, 2024 | 225.30M | 4.16% |
Apr 5, 2024 | 216.30M | 0.98% |
Apr 4, 2024 | 214.20M | -4.46% |
Apr 3, 2024 | 224.20M | -1.41% |
Apr 2, 2024 | 227.40M | -2.70% |
Apr 1, 2024 | 233.70M | -15.39% |
Mar 28, 2024 | 276.20M | -29.34% |
Mar 27, 2024 | 390.90M | 4.91% |
Mar 26, 2024 | 372.60M | 16.04% |
Mar 25, 2024 | 321.10M | -2.10% |
Mar 22, 2024 | 328.00M | 8.54% |
Mar 21, 2024 | 302.20M | -0.36% |
Mar 20, 2024 | 303.30M | 8.05% |
Mar 19, 2024 | 280.70M | -5.65% |
Mar 18, 2024 | 297.50M | -3.25% |
Mar 15, 2024 | 307.50M | 4.17% |
Mar 14, 2024 | 295.20M | -10.98% |
Mar 13, 2024 | 331.60M | 6.56% |
Mar 12, 2024 | 311.20M | 0.52% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Abeona Therapeutics | 212.55M |
X4 Pharmaceuticals | 212.44M |
Zevra Therapeutics | 211.49M |
Cardiff Oncology | 208.64M |
Design Therapeutics | 207.63M |
Lifecore Biomedical | 201.92M |
Compass Therapeutics | 200.03M |
Atossa Therapeutics | 199.23M |